Jeremy D. Walston,Peter M. Abadir,Alka Jain,Neal Fedarko
申请号：
US15769617
公开号：
US20180306786A1
申请日:
2016.10.28
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention described herein provides methods for treating a disease or disorder associated with angiotensin receptor signaling in a patient exhibiting elevated levels of ATIR autoantibodies. The invention also provides methods of identifying a patient suffering from a disease or disorder associated with angiotensin receptor signaling that may benefit from treatment with an angiotensin receptor blocker. Patients with elevated levels of ATIR autoantibodies are identified as candidates that particularly benefit from treatment with an angiotensin receptor blocker.
